Table 2.
Correlations between the frequencies of B cell subsets and clinical features of all the study subjects.
| CD19+ B cells | Bregs | Plasmablasts | Tim-1+ Bregs | IL-10+ Bregs | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| r | P value | r | P value | r | P value | r | P value | r | P value | |
| Male a | 0.04 | 0.68 | 0.02 | 0.81 | -0.06 | 0.56 | -0.13 | 0.19 | -0.01 | 0.89 |
| Age | -0.18 | 0.07 | 0.15 | 0.11 | -0.17 | 0.08 | 0.10 | 0.33 | 0.76 | 0.45 |
| TG a | -0.14 | 0.16 | 0.08 | 0.43 | -0.10 | 0.34 | 0.11 | 0.29 | 0.15 | 0.13 |
| TC | -0.07 | 0.49 | 0.11 | 0.28 | -0.15 | 0.14 | 0.05 | 0.63 | 0.01 | 0.95 |
| LDL-C | -0.10 | 0.35 | 0.18 | 0.07 | -0.07 | 0.50 | 0.02 | 0.86 | -0.02 | 0.83 |
| HDL-C | 0.14 | 0.15 | -0.12 | 0.25 | -0.11 | 0.28 | 0.01 | 0.91 | -0.00 | 0.99 |
| FBG a | -0.08 | 0.44 | -0.19 | 0.06 | -0.12 | 0.23 | -0.25 | 0.01* | -0.22 | 0.03* |
| HbA1c | -0.01 | 0.93 | -0.14 | 0.16 | -0.08 | 0.44 | -0.15 | 0.12 | -0.20 | 0.04* |
| FCP a | -0.18 | 0.07 | 0.17 | 0.08 | -0.02 | 0.86 | 0.23 | 0.02* | 0.37 | 0.00*** |
| GADA a | -0.09 | 0.55 | 0.19 | 0.20 | 0.26 | 0.07 | -0.01 | 0.92 | -0.10 | 0.48 |
| IA-2A a | -0.01 | 0.93 | -0.07 | 0.62 | 0.25 | 0.09 | 0.14 | 0.34 | 0.10 | 0.48 |
| ZnT8A a | 0.19 | 0.20 | -0.07 | 0.63 | 0.02 | 0.91 | -0.05 | 0.73 | -0.07 | 0.64 |
Correlation analyses between various B cell subset frequencies (after log transformation) and clinical features were performed by Pearson test.
a
compared by spearman correlations. * indicates significance (P < 0.05), *** indicates significance (P < 0.001).